4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ: RXRX).The company has emerged as a leader in drug discovery, enabled by artificial intelligence (AI) and a unique platform that it believes could revolutionize medicine. However, Recursion has yet to bring a drug to the market, and its uncertain outlook has resulted in an extremely volatile stock price -- down about 53% in the past year.Here are four things you should know if you're thinking of buying Recursion Pharmaceuticals stock.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool